We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MNMD Mind Medicine MindMed Inc

0.2399 (7.27%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 593,131
Bid Price 3.37
Ask Price 3.54
News -
Day High 3.53


52 Week Range


Day Low 3.28
Company Name Stock Ticker Symbol Market Type
Mind Medicine MindMed Inc MNMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.2399 7.27% 3.5399 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.37 3.28 3.53 3.52 3.30
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,612 593,131 $ 3.43 $ 2,034,126 - 2.12 - 5.01
Last Trade Time Type Quantity Stock Price Currency
19:59:10 2 $ 3.52 USD

Mind Medicine MindMed Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.81M 40.09M - 0 -56.8M -1.42 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Mind Medicine MindMed News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No MNMD Message Board. Create One! See More Posts on MNMD Message Board See More Message Board Posts

Historical MNMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.753.532.753.12445,5720.789928.72%
1 Month2.763.532.412.84389,9620.779928.26%
3 Months3.994.512.413.16374,126-0.4501-11.28%
6 Months3.525.012.413.76478,6640.01990.57%
1 Year2.565.012.123.50494,1180.979938.28%
3 Years86.5586.552.1229.043,476,463-83.01-95.91%
5 Years86.5586.552.1229.043,476,463-83.01-95.91%

Mind Medicine MindMed Description

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |